Distraction Osteogenesis for Craniofacial Defects
Customize your policy alerts
Sign up for Aetna Policy 0549 alerts
Get alerted when Policy 0549 changes without checking for updates manually.
Monitor payer policy activity
This policy governs when Aetna considers distraction osteogenesis medically necessary or experimental/investigational for treatment of congenital craniofacial skeletal deformities and related indications, and lists coding and policy limitations relevant to providers and members.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.